Stay updated on 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.

Latest updates to the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page
- Check7 days agoChange DetectedThe page shows an updated Revision: v3.6.2, replacing the previous v3.6.0, indicating a deployment or template update rather than a change to trial data.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now indicates that recruitment is no longer active and adds guidance sections to help users read the study record and learn how to join a study. It also adjusts the Intervention/Treatment header formatting and updates the template version to v3.6.0, removing the older v3.5.5 text.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating a small update to the page's template/versioning.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a site version update or maintenance patch rather than a change to the study details.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page’s UI release marker was updated from revision v3.5.2 to v3.5.3, indicating a platform/version change without changing the underlying study information.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.